Utilizing machine learning (ML) alongside mass spectrometry, UF Health researchers enhanced meningioma tumor assessment accuracy to 87%. Published in the Journal of the American Society for Mass Spectrometry, this study showcased ML’s prowess in…
Continue Reading
Background: Diagnostic delays in autism are common, with the time to diagnosis being up to 3 years from the onset of symptoms. Such delays have a proven detrimental effect on individuals and families going…
Continue Reading
Neurophet scores $15M in Series C funding, announces 2024 IPOSouth Korean company Neurophet, a provider of brain image analysis software, has raised 20 billion won ($15 million) in a Series C funding round participated by…
Continue Reading
What You Should Know:
– 23andMe has launched 23andMe+ Total Health, a comprehensive prevention-based health membership.
– Total Health provides clinical-grade exome sequencing, biannual blood testing, genetics-based clinical care, and access to clinicians trained in genetics.
Comprehensive,…
Continue Reading
Empatica receives US Food and Drug Administration (FDA) 510(k) clearance for two new digital biomarkers for its Empatica Health Monitoring Platform
What You Should Know:
– Empatica, a digital health and AI company, has obtained FDA…
Continue Reading
Viome Life Sciences, maker of at-home tests for gut and immune system health, announced it has acquired digital health and wellness data company Naring Health, including its subsidiaries DiscernDX and Foodome. Viome is split into…
Continue Reading
Philips and Quibim have teamed up to develop AI-enhanced MR imaging and reporting solutions for prostate exams. This partnership aims to improve prostate cancer care efficiency and accuracy, providing an alternative to traditional PSA…
Continue Reading
What You Should Know:
– 23andMe, a genetic health and biopharmaceutical company launched Health Action Plan, a new digital tool for 23andMe+ members that draws on results from genetic reports, health history survey data, as…
Continue Reading
Oded Kraft, Co-Founder & CEO of GrayMatters Health
We are living in a mental health epidemic. An estimated 26 percent of Americans ages 18 and older – about one in four adults – suffer from…
Continue Reading
Digital biomarkers – data collected by wearable digital medical devices – can be used to inform the development of new drugs and medical devices and to evaluate their effectiveness. Listen as Jordan Brayanov and…
Continue Reading
